| Předmět: |
|
| Zdroj: |
Drug Week; 3/31/2023, p1539-1539, 1p |
| Abstrakt: |
According to the news reporters, the research concluded: "Pharmacist-driven ESA dosing was associated with significant decreases in ESA average acquisition cost and average total dose per patient." Keywords: Melbourne; State:Florida; United States; North and Central America; Biologicals; Colony Stimulating Factors; Cytokines; Dialysis; Drugs and Therapies; Epoetin Alfa; Epoetin Alfa Therapy; Glycoproteins; Health and Medicine; Hematopoietic Cell Growth Factors; Hemodialysis; Intercellular Signaling Peptides and Proteins; Mergers and Acquisitions; Pharmaceuticals; Recombinant Erythropoietin; Recombinant Human Erythropoietins EN Melbourne State:Florida United States North and Central America Biologicals Colony Stimulating Factors Cytokines Dialysis Drugs and Therapies Epoetin Alfa Epoetin Alfa Therapy Glycoproteins Health and Medicine Hematopoietic Cell Growth Factors Hemodialysis Intercellular Signaling Peptides and Proteins Mergers and Acquisitions Pharmaceuticals Recombinant Erythropoietin Recombinant Human Erythropoietins 1539 1539 1 03/27/23 20230331 NES 230331 2023 MAR 31 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Data detailed on Dialysis - Hemodialysis have been presented. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
